Cardiovascular Disease
Myocardial perfusion scintigraphy may be diagnostic tool for asymptomatic patients with diabetes
Published in Health and Medicine Week, October 23rd, 2006
According to a study from Netherlands, "With diabetes, in particular patients with type 2 diabetes, are at a 2-to 4-fold higher risk of cardiovascular mortality compared with their nondiabetic peers. Patients with diabetes are also more likely to have silent ischemia and less likely to survive a myocardial infarction than nondiabetic patients."
"Recent studies with electron beam computed tomography (EBCT) have shown that subclinical atherosclerosis is common in patients with diabetes, and studies with myocardial perfusion...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Diet & Nutrition
Television viewing is linked to higher consumption of unhealthy foods among youth - Healthcare Policy
Americans will face critical shortage of doctors - Mental Health
Men suffer with compulsive buying disorder almost as much as women - Sleep Research
Negative effects of caffeine are stronger on daytime recovery sleep than on nocturnal sleep - Tobacco Use
Lifelong avoidance of tobacco and moderate alcohol consumption benefit life expectancy - Abdominoplasty
Obesity at time of abdominoplasty impacts wound complication rate following surgery - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
